OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center

North Carolina’s only public NCI-designated comprehensive cancer center will work with OncLive to educate the oncology community on ongoing cancer prevention, treatment, and research programs.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
'We are excited and honored to partner with UNC Lineberger Comprehensive Cancer Center to support their mission of reducing cancer occurrence and death through research, treatment, training, and outreach.'

Plainsboro, N.J. (PRWEB) July 23, 2014

OncLive® is pleased to announce that UNC Lineberger Comprehensive Cancer Center has joined its Strategic Alliance Partnership program.

By participating in the Strategic Alliance Partnership program, UNC Lineberger will have the opportunity to work with the OncLive team to raise awareness of its cutting-edge research initiatives, community-directed cancer prevention programs, and other projects. Experts from UNC Lineberger will work with OncLive to educate their peers by providing insights and analysis on the latest news and discoveries in oncology.

UNC Lineberger is a National Cancer Institute-designated comprehensive cancer center, one of only 41 such organizations in the country, and has been providing multidisciplinary, patient-centered care for more than a quarter century. The clinicians and researchers at UNC Lineberger have also been at the forefront of applying advanced technologies such as Intensity Modulated Radiation therapy, Intraoperative Radiation Therapy, and robotic surgery in the treatment of cancer.

In addition to leading important cancer epidemiology and cancer prevention and control programs that examine patterns of cancer in the community to understand the complex interaction among genetics, biology, environmental exposures and behaviors that cause cancer, UNC Lineberger researchers and clinicians also run research programs in Cancer Cell Biology, Immunology, Molecular Carcinogenesis, Cancer Genetics, Molecular Therapeutics, and Virology that investigate the molecular and genetic basis of cancer and progression.

Mike Hennessy, Jr., Vice President of Sales and Marketing and leader of the oncology division of Intellisphere, the publisher of OncLive, said, “UNC Lineberger Comprehensive Cancer Center is an internationally recognized and respected leader in comprehensive cancer research, treatment, and support. We are excited and honored to partner with them to support their mission of reducing cancer occurrence and death through research, treatment, training, and outreach.”

To date, more than 20 cancer centers, nursing schools, and other groups have joined OncLive’s Strategic Alliance Partnership program.

To learn more about OncLive®, visit http://www.OncLive.com.

###

About OncLive®
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research, and education. To learn more, please visit http://www.OncLive.com.

About UNC Lineberger Comprehensive Cancer Center
One of only 41 NCI-designated comprehensive cancer centers, the University of North Carolina Lineberger Comprehensive Cancer Center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer. With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials. For more information, please visit http://www.unclineberger.org.

Media Contact:
Courtney Dysart
For OncLive
267-932-8760 (Office)
courtney(at)hornercom(dot)com


Contact